These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 22479637)

  • 1. IFITM proteins restrict antibody-dependent enhancement of dengue virus infection.
    Chan YK; Huang IC; Farzan M
    PLoS One; 2012; 7(3):e34508. PubMed ID: 22479637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of Dengue/Zika Virus Pathogenicity by Antibody-Dependent Enhancement and Strategies to Protect Against Enhancement in Zika Virus Infection.
    Khandia R; Munjal A; Dhama K; Karthik K; Tiwari R; Malik YS; Singh RK; Chaicumpa W
    Front Immunol; 2018; 9():597. PubMed ID: 29740424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus.
    Brass AL; Huang IC; Benita Y; John SP; Krishnan MN; Feeley EM; Ryan BJ; Weyer JL; van der Weyden L; Fikrig E; Adams DJ; Xavier RJ; Farzan M; Elledge SJ
    Cell; 2009 Dec; 139(7):1243-54. PubMed ID: 20064371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody with an engineered Fc region as a therapeutic agent against dengue virus infection.
    Ramadhany R; Hirai I; Sasaki T; Ono K; Ramasoota P; Ikuta K; Kurosu T
    Antiviral Res; 2015 Dec; 124():61-8. PubMed ID: 26522769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dengue virus compartmentalization during antibody-enhanced infection.
    Ong EZ; Zhang SL; Tan HC; Gan ES; Chan KR; Ooi EE
    Sci Rep; 2017 Jan; 7():40923. PubMed ID: 28084461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of dendritic cells in antibody-dependent enhancement of dengue virus infection.
    Boonnak K; Slike BM; Burgess TH; Mason RM; Wu SJ; Sun P; Porter K; Rudiman IF; Yuwono D; Puthavathana P; Marovich MA
    J Virol; 2008 Apr; 82(8):3939-51. PubMed ID: 18272578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Autophagy-Mediated Dengue Virus Antibody-Dependent Enhancement Infection of THP-1 Cells.
    Jiang L; Sun Q
    Intervirology; 2020; 63(1-6):57-65. PubMed ID: 33202415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maternally Acquired Zika Antibodies Enhance Dengue Disease Severity in Mice.
    Fowler AM; Tang WW; Young MP; Mamidi A; Viramontes KM; McCauley MD; Carlin AF; Schooley RT; Swanstrom J; Baric RS; Govero J; Diamond MS; Shresta S
    Cell Host Microbe; 2018 Nov; 24(5):743-750.e5. PubMed ID: 30439343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of an antibody-dependent enhancement assay for dengue virus using stable BHK-21 cell lines expressing Fc gammaRIIA.
    Moi ML; Lim CK; Kotaki A; Takasaki T; Kurane I
    J Virol Methods; 2010 Feb; 163(2):205-9. PubMed ID: 19781573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dengue virus neutralization and antibody-dependent enhancement activities of human monoclonal antibodies derived from dengue patients at acute phase of secondary infection.
    Sasaki T; Setthapramote C; Kurosu T; Nishimura M; Asai A; Omokoko MD; Pipattanaboon C; Pitaksajjakul P; Limkittikul K; Subchareon A; Chaichana P; Okabayashi T; Hirai I; Leaungwutiwong P; Misaki R; Fujiyama K; Ono K; Okuno Y; Ramasoota P; Ikuta K
    Antiviral Res; 2013 Jun; 98(3):423-31. PubMed ID: 23545366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cytokine response of U937-derived macrophages infected through antibody-dependent enhancement of dengue virus disrupts cell apical-junction complexes and increases vascular permeability.
    Puerta-Guardo H; Raya-Sandino A; González-Mariscal L; Rosales VH; Ayala-Dávila J; Chávez-Mungía B; Martínez-Fong D; Medina F; Ludert JE; del Angel RM
    J Virol; 2013 Jul; 87(13):7486-501. PubMed ID: 23616663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defining New Therapeutics Using a More Immunocompetent Mouse Model of Antibody-Enhanced Dengue Virus Infection.
    Pinto AK; Brien JD; Lam CY; Johnson S; Chiang C; Hiscott J; Sarathy VV; Barrett AD; Shresta S; Diamond MS
    mBio; 2015 Sep; 6(5):e01316-15. PubMed ID: 26374123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dengue virus (DENV) antibody-dependent enhancement of infection upregulates the production of anti-inflammatory cytokines, but suppresses anti-DENV free radical and pro-inflammatory cytokine production, in THP-1 cells.
    Chareonsirisuthigul T; Kalayanarooj S; Ubol S
    J Gen Virol; 2007 Feb; 88(Pt 2):365-375. PubMed ID: 17251552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A plant-produced vaccine protects mice against lethal West Nile virus infection without enhancing Zika or dengue virus infectivity.
    Lai H; Paul AM; Sun H; He J; Yang M; Bai F; Chen Q
    Vaccine; 2018 Mar; 36(14):1846-1852. PubMed ID: 29490880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substitution of the precursor peptide prevents anti-prM antibody-mediated antibody-dependent enhancement of dengue virus infection.
    Wang Y; Si LL; Guo XL; Cui GH; Fang DY; Zhou JM; Yan HJ; Jiang LF
    Virus Res; 2017 Feb; 229():57-64. PubMed ID: 27939945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody-dependent enhancement of dengue virus infection in vitro by undiluted sera from monkeys infected with heterotypic dengue virus.
    Ito M; Mukai RZ; Takasaki T; Kotaki A; Kurane I
    Arch Virol; 2010 Oct; 155(10):1617-24. PubMed ID: 20644969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell type specificity and host genetic polymorphisms influence antibody-dependent enhancement of dengue virus infection.
    Boonnak K; Dambach KM; Donofrio GC; Tassaneetrithep B; Marovich MA
    J Virol; 2011 Feb; 85(4):1671-83. PubMed ID: 21123382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The expression profile of human peripheral blood mononuclear cell miRNA is altered by antibody-dependent enhancement of infection with dengue virus serotype 3.
    Jiang L; Sun Q
    Virol J; 2018 Mar; 15(1):50. PubMed ID: 29566761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody-dependent enhancement of dengue virus infection is inhibited by SA-17, a doxorubicin derivative.
    Ayala-Nuñez NV; Jarupathirun P; Kaptein SJ; Neyts J; Smit JM
    Antiviral Res; 2013 Oct; 100(1):238-45. PubMed ID: 23994499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unfolded protein response (UPR) gene expression during antibody-dependent enhanced infection of cultured monocytes correlates with dengue disease severity.
    Paradkar PN; Ooi EE; Hanson BJ; Gubler DJ; Vasudevan SG
    Biosci Rep; 2011 Jun; 31(3):221-30. PubMed ID: 20858223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.